Exchange: NASDAQ Sector: Healthcare Industry: Health Information Services
Current Signal: SELL (auto-tracking)
2.97% $7.22
America/New_York / 28 mar 2024 @ 10:46
FUNDAMENTALS | |
---|---|
MarketCap: | 2 851.29 mill |
EPS: | -0.0200 |
P/E: | -360.92 |
Earnings Date: | May 07, 2024 |
SharesOutstanding: | 395.00 mill |
Avg Daily Volume: | 1.718 mill |
RATING 2024-03-27 |
---|
A- |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Strong Buy | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
Revenue | ||||||
Gr.Profit | ||||||
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -360.92 | sector: PE -3.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -360.92 | industry: PE -4.88 |
DISCOUNTED CASH FLOW VALUE |
---|
$7.34 (1.68%) $0.121 |
Date: 2024-03-28 |
Expected Trading Range (DAY) |
---|
$ 6.76 - 7.65 ( +/- 6.13%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-16 | Wagner Scott | Buy | 908 739 | Stock Option (Right to Buy) |
2024-03-16 | Wagner Scott | Buy | 564 732 | Restricted Stock Unit |
2024-03-12 | Nabiey Romin | Buy | 51 462 | Stock Option (Right to Buy) |
2024-03-12 | Nabiey Romin | Buy | 35 716 | Restricted Stock Unit |
2024-03-12 | Voermann Karsten | Buy | 515 793 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-7.92 |
Last 99 transactions |
Buy: 60 781 906 | Sell: 71 719 828 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $7.22 (2.97% ) |
Volume | 0.312 mill |
Avg. Vol. | 1.718 mill |
% of Avg. Vol | 18.14 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % | Feb 8 - 15:35 | buy | $6.45 | N/A | Active |
---|
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.